Thu, 21 May 2026
12:30:18 pm
Rudransh Sangwan
Published at: May 21, 2026, 11:19 AM
Synopsis
Apollo Hospitals confirmed progress in the Apollo HealthCo demerger process, targeting a Q4 FY27 listing and a ₹25,000 crore annual revenue goal. The healthcare stock has surged nearly 158% over the last five years amid strong growth in hospitals, digital healthcare, pharmacy, and healthcare platform expansion.

Apollo Hospitals Enterprise Limited has confirmed that the demerger process of Apollo HealthCo is progressing, with the company targeting a separate listing by Q4 FY27 and setting an ambitious ₹25,000 crore annual revenue target for the demerged entity.
The healthcare stock has remained in strong focus after delivering a massive 158% return over the last five years, supported by aggressive healthcare expansion, digital health growth, pharmacy business scaling, and strong investor optimism surrounding the Apollo HealthCo demerger story.
The latest update was shared during a recent concall, where the company confirmed that a shareholder meeting related to the demerger process has been scheduled for June 24, 2026.
Apollo Hospitals stated that the demerger process is moving ahead as planned, with the company aiming to unlock value through the separate listing of Apollo HealthCo.
| Parameter | Details |
|---|---|
| Company | Apollo Hospitals Enterprise Limited |
| Entity Being Demerged | Apollo HealthCo |
| Shareholder Meeting Date | June 24, 2026 |
| Target Listing Timeline | Q4 FY27 |
| Revenue Target | ₹25,000 Crore |
| Update Source | Concall Update |
Loading chart...
The proposed restructuring is expected to provide greater operational focus, financial transparency, and independent growth opportunities for Apollo HealthCo.
Apollo Hospitals has set a bold annual revenue target of ₹25,000 crore for Apollo HealthCo, reflecting the scale at which the company expects the healthcare and pharmacy platform to operate following the demerger.
The target highlights the company’s confidence in growth across:
The Apollo HealthCo demerger is viewed as one of the most significant healthcare restructuring developments in India’s listed healthcare space.
| Strategic Factor | Expected Impact |
|---|---|
| Separate Listing | Independent Valuation Unlock |
| Operational Focus | Improved Business Efficiency |
| Healthcare Platform Expansion | Faster Growth Scalability |
| Digital Health Push | Higher Consumer Reach |
| Revenue Visibility | Long-Term Growth Potential |
The move could potentially help Apollo unlock higher shareholder value by separating its healthcare platform and retail-focused operations from the hospital business.
Apollo Hospitals has continued expanding its integrated healthcare ecosystem across:
The company remains one of India’s largest private healthcare operators with a strong presence across physical healthcare infrastructure and technology-enabled healthcare services.
India’s healthcare sector continues attracting strong investor attention driven by:
Healthcare companies with integrated ecosystems and digital capabilities are increasingly being viewed as long-term structural growth stories.
Apollo Hospitals stock has delivered strong long-term returns amid consistent business expansion and improving healthcare demand trends.
| Period | Stock Return |
|---|---|
| 1 Day | +2.85% |
| 5 Days | +3.80% |
| 1 Month | +8.51% |
| 6 Months | +11.93% |
| 1 Year | +20.20% |
| 5 Years | +158.03% |
The sharp 158% rally over five years reflects strong market confidence in Apollo Hospitals’ long-term healthcare growth strategy and platform expansion opportunities.
With Apollo HealthCo’s demerger progressing toward a targeted Q4 FY27 listing and management outlining a ₹25,000 crore revenue ambition, Apollo Hospitals continues positioning itself as a major player in India’s evolving healthcare and digital health ecosystem.
The restructuring could become a major long-term value unlocking trigger for investors as the company scales its healthcare platform business independently.
Apollo HealthCo is the healthcare and pharmacy-focused business entity of Apollo Hospitals that includes digital healthcare, pharmacy operations, and consumer healthcare services.
Apollo Hospitals confirmed that the demerger process of Apollo HealthCo is progressing and the company is targeting a separate listing by Q4 FY27.
The shareholder meeting related to the demerger process is scheduled for June 24, 2026.
Apollo Hospitals has set an annual revenue target of ₹25,000 crore for Apollo HealthCo.
The company is targeting a separate listing of Apollo HealthCo in Q4 FY27, subject to regulatory and shareholder approvals.
The demerger could unlock shareholder value, improve operational focus, and allow independent scaling of Apollo’s healthcare platform and pharmacy business.
Apollo Hospitals stock has delivered approximately 158% returns over the last five years.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

DEE Development Engineers’ subsidiary secured a long-term HRSG pipe spool fabrication order worth a minimum of US$15.

Mayur Uniquoters reported a 43% jump in FY26 net profit to ₹1,917.40 crore with revenue rising to ₹10,220.76 crore.

Lenskart reported a 147.7% jump in FY26 adjusted PAT to ₹5,300 million as revenue rose 32.3% to ₹90,023 million.

Pace Digitek secured a ₹2,64,650 lakh BSNL contract for the Sikkim Middle Mile Network under the BharatNet initiative.

Orient Green Power subsidiary Beta Wind Farm secured a ₹62 crore EPC contract from Renfra Energy India to develop a 6.